Esteban Herrero-Martinez
Esteban Herrero-Martinez is Director, Regulatory Policy & Intelligence, AbbVie. He received his BSc in Biochemistry from Warwick University, a PhD in Virology from University College London, and his postdoc from Imperial College London. He has held a number of leadership positions, including Director of Regulatory Intelligence & Policy at Daiichi Sankyo Development Ltd, and Lead for Pharmacovigilance & Regulatory Affairs at ABPI.
![[FROM LEFT] Claudia Popp, Olga Tkachenko and Marta Carnielli](https://ds982gbwnvyso.cloudfront.net/Pictures/100x67/4/4/1/441_5m4a4767_toprasymposium2022_day3_20221019_816643.jpg)
Meeting ReportIVD1: Current state –
and update on IVDR implementationThis session focused on the implementation of the IVDR which went live on 26 May 2022.
Meeting ReportIVD2: Clinical Performance Evaluation Challenges
We are in a transition phase until EUDAMED is fully functional. Local Agency procedures must still be followed despite the IVDR go-live – this is administratively challenging.